On 07/09/2025 Teva discontinued distribution of the AirDuo® RespiClick® (fluticasone propionate and salmeterol) Inhalation Powder in the US. As of July 9, 2025, Teva will no longer be selling product to wholesalers, but inventory in the channel will be available to be purchased and used until inventory is exhausted for patients and HCPs. However, people who already have and are using AirDuo RespiClick inhalers can continue using them as prescribed until their expiration date.
Since AirDuo Respiclick inhalers will no longer be manufactured or distributed to wholesalers after 7/9/2025, patients and healthcare providers should consider appropriate therapeutic alternatives. Teva will continue to have an Authorized Generic version of AirDuo RespiClick available for use for HCPs and patients.
Please see full Prescribing Information for AirDuo RespiClick.
For medical or clinical questions please contact Teva US Medical Information at 1-888-483-8279 (M-F 9AM to 5PM EST) or by emailing USMedInfo@tevapharm.com
INHALE CQI: MICMT and INHALE are partnering to provide this service to practices and POs participating in the INHALE CQI. Nada serves on the INHALE education workgroup and can help provide resources specific to your practice site. General educational resources related to INHALE are available to all practices (regardless of participation in the CQI) at INHALE Resources.
Details: Slots are 30 minutes long and there is a maximum of 2 slots per month. Prior to your session, please complete the following form as well: Consult Questionnaire.
If you’re interested in a consultation with our partner pharmacist, sign up here.
Now available on the INHALE website and linked below is a flyer that can be shared with providers who care for those with asthma. The flyer outlines the Flovent discontinuation, available alternatives for the medication and the dosing recommendations. Click to access the flyer and dosing charts.
To assist providers in finding covered medications for their patients, a free Coverage Search app is available for download in the Apple and Google app stores. The app includes access to accurate and timely formulary status at your fingertips. Learn more about the app and it’s features here.
INHALE prepares regular PO and Clinical level newsletters that contain:
Arbor Lakes Building 3, Floor 3
4251 Plymouth Rd.
Ann Arbor, MI 48105
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.